
<!-- saved from url=(0060)http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=windows-1252">
<title>Project Presentations</title>

</head><body bgcolor="#FFFFFF" text="#000000">

<a name="Top"></a>

<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="668" style="width:500.7pt;margin-left:4.8pt;border-collapse:collapse;mso-yfti-tbllook:
 1184;mso-padding-alt:0in 5.4pt 0in 5.4pt">
  <tbody><tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#D9D9D9;
  mso-background-themecolor:background1;mso-background-themeshade:217;
  padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Name<o:p></o:p></span></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#D9D9D9;
  mso-background-themecolor:background1;mso-background-themeshade:217;
  padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Title<o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;background:#D9D9D9;
  mso-background-themecolor:background1;mso-background-themeshade:217;
  padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Schedule<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:1;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#FDE9D9;
  mso-background-themecolor:accent6;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><b><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Harmeet</span></b></span><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"><o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#FDE9D9;
  mso-background-themecolor:accent6;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Harmeet">Bioperl
Tools: Harmeet's 
        Translator and RSLocator</a><o:p></o:p></span></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  mso-border-alt:solid windowtext .5pt;background:#FDE9D9;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">6:00<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:2;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#F2DBDB;
  mso-background-themecolor:accent2;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><b><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Tanzeema</span></b></span><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"><o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#F2DBDB;
  mso-background-themecolor:accent2;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Tanzeema">Investigation 
        of HSA-drug interactions using structure visualization tools</a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #F2DBDB;mso-background-themecolor:accent2;mso-background-themetint:51;
  padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">6:15<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:3;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#FDE9D9;
  mso-background-themecolor:accent6;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><b><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Jyoti</span></b></span><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"><o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#FDE9D9;
  mso-background-themecolor:accent6;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Jyoti">Studying 
        the characteristics of psoriatic arthritis genes and common genetic control 
        for <span class="SpellE">Crohn’s</span> disease and psoriatic arthritis 
        in the pathway.</a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #FDE9D9;padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">6:30<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:4;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#F2DBDB;
  mso-background-themecolor:accent2;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><b><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Danh</span></b></span><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"><o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#F2DBDB;
  mso-background-themecolor:accent2;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"> <a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Danh"> 
Pulmonary Valve Disease Study</a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #F2DBDB;mso-background-themecolor:accent2;mso-background-themetint:51;
  padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">6:45<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:5;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#FDE9D9;
  mso-background-themecolor:accent6;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Annie<o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#FDE9D9;
  mso-background-themecolor:accent6;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Annie">
Integration of the Metabolic Pathway of Gout and its Treatments Using IPA and NCBI
</a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #FDE9D9;padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">7:00<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:6;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#F2DBDB;
  mso-background-themecolor:accent2;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Chris<o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#F2DBDB;
  mso-background-themecolor:accent2;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Chris">The 
        human chimp twist of evolution</a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #F2DBDB;mso-background-themecolor:accent2;mso-background-themetint:51;
  padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">7:15<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:7;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#FDE9D9;
  mso-background-themecolor:accent6;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Erin<o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#FDE9D9;
  mso-background-themecolor:accent6;mso-background-themetint:51;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Erin">An 
        Exploration of Polymorphism and Copy Number Variation Associated with Parkinson’s Disease</a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #FDE9D9;padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">7:30<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:8;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#E5B8B7;
  mso-background-themecolor:accent2;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><a name="2nd"></a><b>
<span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
Jennifer<o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#E5B8B7;
  mso-background-themecolor:accent2;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Jennifer">Pharmacogenomics and Bioinformatics</a><o:p></o:p></span></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #E5B8B7;mso-background-themecolor:accent2;mso-background-themetint:102;
  padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">8:00<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:9;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#FBD4B4;
  mso-background-themecolor:accent6;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Nancy<o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#FBD4B4;
  mso-background-themecolor:accent6;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Nancy">Bioinformatics 
        tools for molecular <span class="SpellE">cytogenetics</span></a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #FAC090;padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">8:15<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:10;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#E5B8B7;
  mso-background-themecolor:accent2;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><b><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Parag</span></b></span><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"><o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#E5B8B7;
  mso-background-themecolor:accent2;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Parag">Connecting 
        genes of Parkinson’s Disease</a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #E5B8B7;mso-background-themecolor:accent2;mso-background-themetint:102;
  padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">8:30<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:11;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#FBD4B4;
  mso-background-themecolor:accent6;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><b><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Sukhpreet</span></b></span><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"><o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#FBD4B4;
  mso-background-themecolor:accent6;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Sukhpreet">Exploring the Molecular Phylogeny of Elephantidae</a></span></span></p><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Sukhpreet">
    </a></td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #FAC090;padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">8:45<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:12;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#E5B8B7;
  mso-background-themecolor:accent2;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><b><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Harshal</span></b></span><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"><o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#E5B8B7;
  mso-background-themecolor:accent2;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Harshal">Exploring 
        genetic resistance to HIV and the Black Death</a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #E5B8B7;mso-background-themecolor:accent2;mso-background-themetint:102;
  padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">9:00<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:13;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#FBD4B4;
  mso-background-themecolor:accent6;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><b><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Priyanka</span></b></span><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"><o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#FBD4B4;
  mso-background-themecolor:accent6;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Priyanka">Breast 
        cancer bioinformatics</a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #FAC090;padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">9:15<o:p></o:p></span></p>
    </td>
  </tr>
  <tr style="mso-yfti-irow:14;mso-yfti-lastrow:yes;height:23.25pt"> 
    <td width="163" nowrap="" valign="bottom" style="width:122.1pt;background:#E5B8B7;
  mso-background-themecolor:accent2;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span class="SpellE"><b><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Ramya</span></b></span><b><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"><o:p></o:p></span></b></p>
    </td>
    <td width="402" nowrap="" valign="bottom" style="width:301.5pt;background:#E5B8B7;
  mso-background-themecolor:accent2;mso-background-themetint:102;padding:0in 5.4pt 0in 5.4pt;
  height:23.25pt"> 
      <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"><a href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Ramya">Developing 
        a multi-<span class="SpellE">epitope</span> vaccine encoding T-lymphocyte 
        <span class="SpellE">epitopes</span> for treatment of chronic HBV infections using PEPVAC</a><o:p></o:p></span></p>
    </td>
    <td width="103" nowrap="" valign="bottom" style="width:77.1pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;background:
  #E5B8B7;mso-background-themecolor:accent2;mso-background-themetint:102;
  padding:0in 5.4pt 0in 5.4pt;height:23.25pt"> 
      <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal"><span style="font-size:18.0pt;
  mso-ascii-font-family:Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;
  mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO">9:30<o:p></o:p></span></p>
    </td>
  </tr>
</tbody></table>
<p><a name="Harmeet"></a><span class="SpellE">
<span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
Bioperl</span></span><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"> Tools: <span class="SpellE">Harmeet's</span> 
  Translator and <span class="SpellE">RSLocator</span></span></p>

1. It's common for biologists to translate an mRNA sequence into the encoded protein to understand its structure and function. 
2. Locating restriction sites within a DNa sequence is also a common task for analyzing sequences and designing cloning experiments. However, it would tak a long time, depending on the length of the sequences, to translate or locate
restriction enzymes on paper by hand.<br>
Results:
1. Harmeet's Translator, a <a href="http://www.perl.org/">perl</a> prgram, has been developed to translate a given mRNA sequence, in either plain text or FASTA format, into the encoded protein.
2. Harmeet's RSLocator, a perl program, has been developed to accept a DNA sequence, in either plain text or FASTA format, and locate restriction
sites fr any one of the manu restriction enzymes available to choose from.
<br>
AVAILABILITY: Both programs are available for free, see links below<br>
<b>Author: Harmeet Arora</b><br>
<table><tbody><tr> <td><a href="http://home.comcast.net/~igabashvili/Translator">Harmeet's Translator</a></td> <td>&nbsp;</td> 
<td><a href="http://home.comcast.net/~igabashvili/mRNA.fasta">sample mRNA sequence</a></td> </tr>
<tr><td><a href="http://home.comcast.net/~igabashvili/RSLocator">Harmeet's RSLocator</a></td> <td>&nbsp;</td> 
<td><a href="http://home.comcast.net/~igabashvili/DNA.fasta">sample DNA sequence</a></td> </tr></tbody></table>


<p><a name="Tanzeema"></a>
<span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
Investigation 
  of HSA-drug interactions using structure visualization tools</span></p>
<b>Abstract: </b>Bioinformatics has become a vital tool in drug discovery and 
drug development. The effect of human serum albumin (HSA) on drug metabolism was 
investigated by using <a href="http://www.rcsb.org/pdb/">PDB</a>, <a href="">NCBI</a>, 
Robetta server, <a href="http://home.comcast.net/~igabashvili/www.cgl.ucsf.edu/chimera/">Chimera</a> and <a href="http://home.comcast.net/~igabashvili/www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml">CN3D</a> 
structure visualization tools. I chose HSA because, it is the most abundant protein 
in human blood plasma and it plays an important role in drug pharmacokinetics. 
The domain II and III of HSA contain two primary drug binding sites and it basically 
binds with two ligands: myristate and salicylic acid. In addition to its ligand 
binding activity, enzymatic activity of human serum albumin on different drugs 
has been studied and documented. Site directed mutagenesis studies have shown 
that Tyrosine residue (Tyr 411) is important for the esterase activity of human 
serum albumin. The crystal structure of human serum albumin-myristate-aspirin 
illustrates that aspirin transfer acetyl group to Lysine residue and is hydrolyzed 
into salicylic acid by human serum albumin. By calculating the distance between 
two atoms and finding the localization of other atoms we gain an understanding 
of the interaction which occurs between drug and their targets and we can do computational 
drug design. This finally leads to the development of new drugs for people with 
different symptoms and side effects. 
<p>
</p><p style="font-size:smaller;"> <font size="-1"><a class="ModuleContent" href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Top">BACK</a></font> 
</p><p><a name="Jyoti"></a><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Studying 
  the characteristics of <a href="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&term=ARTHRITIS,+PSORIATIC">psoriatic arthritis</a> genes and common genetic control 
  for <a href="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&term=Crohn+Disease&field=entry">Crohn disease</a> and psoriatic <a href="http://www.diseasesdatabase.com/umlsdef.asp?glngUserChoice=15237">arthritis</a> in the 
  pathway.</span></p>
<b>Abstract:</b> <a href="http://clinicaltrials.gov/search/open/condition=%22Arthritis,+Psoriatic%22">Psoriatic arthritis</a> is a systemic inflammatory condition characterized 
by inflammation of the skin and joints. Many genes are involved in this complex 
inflammatory response. A list of key Psoriasis-related genes was assembled using 
Ingenuity pathway analysis to facilitate the identification of interaction between 
these genes. A disease network was build to show various genes interaction. Assisted 
by the <a href="http://ingenuity.com/">Ingenuity Pathway Analysis (IPA)</a> overlapping 
networks (3 Psoriatic arthritis and 2 <a href="http://www.diseasesdatabase.com/ddb3178.htm">Crohn’s disease</a>) were identified. Overlapping 
networks revealed 31 common genes indicating common genetic controls between psoriatic 
arthritis and <a href="http://clinicaltrials.gov/ct2/results?term=%22Crohn%27s+Disease%22">Crohn’s disease</a>. Presence of common genetic controls indicates the 
susceptibility to Crohn’s disease. These intricacies of disease network, functional 
pathways and their contribution in the disease development were also studied as 
an essential tool to provide therapeutic strategies for two diseases. 
<p> 
<span style="font-size:14.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
</span></p><p style="font-size:smaller;"> <font size="-1"><a class="ModuleContent" href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Top">BACK</a></font> 
</p><p> <a name="Danh"></a> 

<font size="+1">
<a href="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&term=HEART+VALVE+DISEASES">Pulmonary Valve Disease</a></font> Study</p>
 
<p><b>Abstract: </b>According to the American Heart Association, heart disease 
  was the leading killer in the United Sttes in 2006. Approximately 1.2 million 
  Americans had heart attacks in 2006.Pulmonary valve <span class="SpellE">stenosis</span>, a major contributor to the death rate of cardiovascular 
  disease, is often present at birth.<span style="mso-spacerun:yes">&nbsp; Stenosis narrows the blood flow pathway to the lung 
  from the right ventricle.<span style="mso-spacerun:yes">&nbsp; </span>This project will utilize <a href="http://ingenuity.com/">Ingenuity Pathway 
  Analysis (IPA)</a> and other bioinformatics databases from <a href="http://www.ncbi.nlm.nih.gov/Entrez/">NCBI</a> 
  to hypothesize potential pathways that may responsible for pulmonary valve <span class="SpellE">stenosis</span>.<span style="mso-spacerun:yes">&nbsp; </span>I will explore all interactions among all the 
  genes, drugs, enzymes and chemical compounds involving in the regulation process 
  that trigger pulmonary valve <span class="SpellE">stenosis</span>.<span style="mso-spacerun:yes">&nbsp; </span>The data suggests that pulmonary valve <span class="SpellE">stenosis</span> is involved in the <span class="SpellE">Neurotrophin</span>/TRK 
  signaling pathway, which initiates by binding to the membrane protein, NTRK3, 
  to activate three major genes – MEF2A, MEF2C, and MEF2D, on the downstream process 
  in heart tissue.<span style="mso-spacerun:yes">&nbsp; </span></span></p>
<p><a class="ModuleContent" href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Top"><font size="-1">BACK</font></a> </p>
<p>
<span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
</span></p><p> <a name="Annie"></a> Integration of the Metabolic Pathway of <a href="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&term=Gout&field=entry">Gout</a> and its 
  Treatments Using <a href="http://ingenuity.com/">IPA</a> and <a href="http://www.ncbi.nlm.nih.gov/Entrez/">NCBI 
  tools</a><br>
[Gout, an exploration of the Royal disease]
 
</p><p> <b>Abstract: </b> This bioinformatics project integrates elements of known 
  information about gout or hyperuricemia. Gout is a uric acid metabolism disorder 
  that is genetically, sex, and diet linked. Overproduction and/or underexcretion 
  of uric acid can cause the uric acid to form crystals in the body’s parts cooler 
  extremities such as the fingers and toes. An immune response then sends neutrophils 
  to attack the crystals, causing painful inflammation. Ingenuity Pathway Analysis 
  and <a href="http://www.ncbi.nlm.nih.gov/Entrez/">NCBI</a> were used to develop 
  pathological relationships between genes, enzymes, and chemical compounds. The 
  genes directly related to gout include SLC22A12 (a urate exchanger), PTGS1, 
  and PTGS2. PTGS 2 is seen to be a central figure in the inflammatory reaction, 
  having interactions with PTGS 1, interleukin 1B, and nuclear factor kappa Beta. 
  PRPS1 is linked on the X chromosome and a mutation in this gene eventually leads 
  to a malfunction on the enzyme known as PPRP. This may lead to the overactivity 
  of PPRP in de novo synthesis of purines. There is another enzyme called HPRT1 
  which works in the salvage pathway of purines from old DNA. An X-linked recessive 
  disorder can lead to partial HPRT deficiency causing an overproduction of uric 
  acid. Drugs like colchicine, probenecid, and NSAIDs have been used to alleviate 
  the symptoms of gout. Inhibiting PTGS2 and even PTGS1 with NSAIDs like aspirin 
  can cause a decrease in the painful inflammation caused by gout. Probenecid 
  is a treatment that binds to SLC22A12 and increases the amount of uric acid 
  that is excreted in the urine. In conclusion, while much is already known about 
  gout, a new pathway of gout was created by using fragments of information derived 
  from bioinformatics tools. </p>
<span></span> 
<p><a name="Chris"></a>
<span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
The 
  human chimp twist of evolution<o:p></o:p></span></p>

<b>Abstract: </b>Mitochondrial DNA contains the critical proteins for cell respiration. 
It has been often used to construct evolutionary trees. In this project, the mitochondrial 
DNA sequence of <i>Homo sapiens</i>(NCBI build 36,3) and <i>Pan troglodytes</i>(NCBI 
build 2.1) were aligned with <a href="http://genome.ucsc.edu/cgi-bin/hgBlat?command=start">UCSC BLAT</a>. A 55 base pair sequence with no homology 
was further examined with BLAT and BLAST alignment tools and determined to be 
part of the 3' UTR of cytochrome c oxydase I. <a href="http://www.sanger.ac.uk/Software/Rfam/">Rfam</a> tool hs been used to examine 
the UTR and showed that this extra sequence can fold into a tRNA-like structure, 
promoting translation of the mRNA. More experiments are needed to examine the 
mechanism of regulation. 
<p style="font-size:smaller;"> <a class="ModuleContent" href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Top">BACK</a></p><p>

</p><p><a name="Erin"></a><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">An 
  Exploration of Polymorphism and Copy Number Variation Associated with <a href="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&term=Parkinson+Disease&field=entry">Parkinson Disease</a><o:p></o:p></span></p>
<p><b>Abstract: </b>Parkinson’s Disease (PD) is a chronic and progressive neurodegenerative 
  disorder characterized by muscle rigidity, tremor, and impairment of physical 
  movement (either <span class="SpellE">bradykinesia</span> or <span class="SpellE">akinesia</span>). 
  The symptoms of PD are caused by the loss of <span class="SpellE">dopaminergic</span> 
  cells and decreased dopamine levels in the brain. There are no known blood or 
  laboratory tests that can be used to diagnose PD. However, many researchers 
  are working to elucidate the genetic mechanisms underlying the disease so that 
  diagnostic tests and/or drugs may become available. To date, several gene mutations 
  have been implicated in the cause of PD:<span style="mso-spacerun:yes">&nbsp; </span>SNCA, 
  LRRK2, PRKN, and PINK1. This paper will review some of the bioinformatics tools 
  that can be used to gather information about two of these genes and also to 
  visualize the disease pathway. I have chosen to explore LRRK2 and PRKN and their 
  role in PD. Specifically, I will report information about gene function and 
  location from the <span class="SpellE">Entrez</span> suite. I will also use <a href="http://www.genome.jp/kegg/">KEGG 
  </a> to visualize the pathway of neurodegenerative disorders. Finally, I will 
  use <a href="http://ingenuity.com/">Ingenuity Pathway Analysis</a> to show interactions 
  involved in the disease.<o:p></o:p> <o:p></o:p></p>
<p>
<span class="SpellE"><span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
</span></span></p><p style="font-size:smaller;"> <font size="-1"><a class="ModuleContent" href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#Top">BACK</a></font>
</p><p><a name="Jennifer"></a><span class="SpellE">
<span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
</span></span><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"> Pharmacogenomics and Bioinformatics</span></p>
<p><span style="font-size:12.0pt;line-height:200%;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;"> 
  </span> <o:p><b>Abstract: </b>

Pharmacogenomics is an emerging field that will advance customizing drug products to each individual.  The study of pharmacogenomics is critical to the individual optimization of a drug in the treatment of a disease.  Single nucleotide polymorphisms (SNPs) are important indicators of the interaction between drugs and proteins.  Cytochrome P540 2C9 (<a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1559&ordinalpos=1&itool=EntrezSystem2.PEntrez.Gene.Gene_ResultsPanel.Gene_RVDocSum">
CYP2C9</a>) is a protein that is part of the cytochrome P450 superfamily of enzymes 
(<a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene">NCBI 
  Entrez Gene</a>). 
It catalyzes reactions involved in drug metabolism, similar to those of warfarin and fluriprofen.  
SNPs of CYP2C9 (<a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp&TabCmd=Limits">SNP 
  database</a>) are critical in the effectiveness of warfarin therapy due its narrow therapeutic tolerance.  I have analyzed two specific SNPs and allelic variances that are associated with CYP2C9 and its interaction with warfarin.  CYP2C9*2 and CYP2C9*3 effect the catalytic activities of S-warfarin in comparison to the wildtype.  I visualized possible interactions of these SNPs and the drug using 
<a href="http://home.comcast.net/~igabashvili/www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml">CN3D</a> software.  
Pharmacogenetics poses important bioethical questions.  Patients' privacy is first and foremost the most important issue surrounding the ethical consideration of pharmacogenetics.  Patients' understanding and distinction of the use of pharmacogenetics in comparison to genetic testing is one of the major obstacles and ethical issues facing pharmacogenetics.  Furthermore, affordability is critical to the patients that are financially limited and will most benefit from personalized medicine

</o:p></p><p><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"></span><font size="-1"><a class="ModuleContent" href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#2nd">BACK</a></font> 
</p>
<span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
<p> <a name="Nancy"></a> Bioinformatics tools for molecular <span class="SpellE"> 
  cytogenetics</span></p>
</span> <b>Abstract: </b>Throughout the last decade, molecular cytogenetics has 
made significant breakthroughs in disease research. It focuses on the cellular 
aspects of heredity, especially chromosome structures, and the identification 
of genomic aberrations that cause disease. Microarrays have significantly contributed 
to such breakthroughs, and provide the coverage and sensitivity needed to identify 
subtle chromosome abnormalities and copy number changes at molecular resolutions. 
Advanced statistical software tools allow researchers to use those data points 
to identify the differences in chromosomal copy number and thus provide additional 
insight into medical and cancer genetics. Using statistical algorithms and visualization 
tools, we performed copy number analysis, detected critical regions of genomic 
losses or gains and identified those regions correlated with disease-associated 
phenotypes. 
<p><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
</span></p><p style="font-size:smaller;"> <a class="ModuleContent" href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#2nd"><font size="-1">BACK</font></a>
</p><p>
<a name="Parag"></a>
Connecting 
  genes of <a href="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&term=Parkinson+Disease&field=entry">Parkinson Disease</a></p>
 
<p><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;
mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-language:LAO"><o:p><b>Abstract: 
  </b>Parkinson's disease (PD) is the most common movement disorder characterized 
  by dopaminergic dysfunction and degeneration. The cause of most PD cases is 
  unknown, some debate still exists as to whether PD is predominantly environmental 
  or genetic in etiology. Early onset Parkinson's disease (EOPD) has been linked 
  to mutations in the DJ-1, PINK1 and PARKIN genes. We investigated the various 
  relationships and similarities between the three genes. Entrez gene, <a href="http://ingenuity.com/">Ingenuity 
  Pathway Analysis (IPA)</a> and BLAST software were primarily used to test the 
  hypothesis. There were no direct relationships between the genes, however, they 
  were indirectly related through camptothecin, Hsp70, and somatic cytochrome 
  c. Camptothecin's, role in the cell is apoptosis. Somatic cytochrome c has a 
  biological process to fragment DNA during apoptosis and Hsp70's role in the 
  cell is also apoptosis. These results suggest that even though the genes were 
  not directly related, they had key similar features and were all associated 
  with cell death.</o:p></span></p>
<p>&nbsp;</p>
<p><a name="Sukhpreet"></a><span class="SpellE">
<span style="font-size:18.0pt;mso-ascii-font-family:
  Calibri;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
</span></span><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;;
  color:black;mso-bidi-language:LAO"> Exploring the Molecular Phylogeny of Elephantidae</span></p>
<p> <span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"> </span> 
  
<b>Abstract: </b>
The phylogenetic relationships in the Elephantidae family have been unclear to this day.  The evolutionary relationships between the extant elephant species Asiatic elephant (<i>Elephas maximus</i>) and African elephant (<i>Loxodonta africana</i>) were examined. The main question that was set out to be answered was which extant species of elephant is most closely related to the Woolly Mammoth (<i>Mammuthus primigenius</i>) and to a lesser extent, the Mastodon (<i>Mammut americanum</i>).  DNA sequences from other closely related species such as the Cape Hyrax (<i>Procavia capensis</i>), Dugong (<i>Dugong dugon</i>), Manatee (<i>Trichechus manatus</i>), and Steller’s Sea Cow (<i>Hydrodamalis gigas</i>) were also analyzed phylogenetically.  Complete mitochondrial cytochrome b sequences of all species were obtained from the <a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene">Entrez Gene database</a> and partial sequences were obtained from the <a href="http://home.comcast.net/~igabashvili/%E2%80%9Dhttp://www.ncbi.nlm.nih.gov/sites/entrez?db=protein%94">Entrez Protein database</a>. GeneDoc was used to do an initial alignment and manual alignments were done to maximize alignment scores.  The Mega4 program was used to apply several different phylogenetic algorithms to construct trees with bootstrap confidence values.  The study was able to determine that the <i>Loxodonta africana</i> and <i>Mammauthus primigenius</i> are more closely related to each other than either is to the <i>Elephas maximus</i>.  A complex evolutionary tree was constructed in which the remaining species were also grouped together and were analyzed for evolutionary history.          

</p><p><a class="ModuleContent" href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#2nd"><font size="-1">BACK</font></a> </p>
<p>&nbsp;</p>
<p> <a name="Harshal"></a><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO"> 
Exploring genetic resistance to HIV and the Black Death</span></p><p>

The Human Immunodeficiency Virus (HIV) is now a pandemic among humans.  However, humans can be resistant to 
the virus if they have a mutated CCR5 gene.  HIV uses CCR5 and CCL3L1 as a co-receptor to enter its target 
cells.  Several chemokine receptors can function as viral co-receptors, but CCR5 is likely the most 
physiologically significant co-receptor during natural infection. CCR5 - delta 32, however, is a 
genetic variant of CCR5 hypothesized to be the favored allele by natural selection during the Black Death, 
and is found to protect against HIV.  While CCR5 has multiple variants in its coding region, the deletion 
of a 32-bp segment results in a non-functional receptor, which prevents HIV R5 entry.  

The  <a href="http://ingenuity.com/">Ingenuity Pathway Analysis</a> (IPA) software is used to build a 
network of interactions between drugs for HIV and receptors on CD4+ T cells.  
New drug targets, receptors, and pathways are investigated.

<br>
See also<a href="http://home.comcast.net/~igabashvili/hiv.htm"> this article</a> 
</p><p><a name="Priyanka"></a>
<span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">
Breast 
  cancer bioinformatics<o:p></o:p></span></p>
<b>Abstract: </b>Breast cancer is the most commonly diagnosed disease in women, 
accountint for 23% of the total cases. It is estimated that approximately 1 in 
11 woman will suffer from the disease some point in their lifetime. In this project, 
we have addressed the following questions:<br>
<li>What are the biomarkers for breast cancer?
</li><li>What are the current therapies for breast cancer?
</li><li>Are the biomarker genes for breast cancer related to other diseases?<br>
  Using <a href="http://ingenuity.com/">IPA</a>, <a href="http://www.genome.jp/kegg/">KEGG 
  Pathway database</a> and <a href="http://www.ncbi.nlm.nih.gov/Entrez/">NCBI 
  tools</a>, we studied pathways, genes involved and drug targets in breast cancer. 
  <p><a name="Ramya"></a><span style="font-size:18.0pt;mso-ascii-font-family:Calibri;
  mso-fareast-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;
  mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-bidi-language:LAO">Developing 
    a multi-<span class="SpellE">epitope</span> vaccine encoding T-lymphocyte <span class="SpellE">epitopes</span> for treatment of chronic HBV infections using <a href="http://immunax.dfci.harvard.edu/PEPVAC/">PEPVAC</a><o:p></o:p></span></p>
  <b>Abstract: </b>Protein sequences from multiple hepatitis B virus (HBV) isolates 
  were analyzed for the presense of amino acid motifs characteristic of cyttoxic 
  (CTL) and helper (HTL) T-lymphocyte epitopes. This was done with the goal of 
  idenfiying conserve epitopes suitable for use in a therapeutic vaccine. Specifically, 
  sequences bearing HLA-A1, -A2, -A3, -A24, -B7, and -DR supertype binding motifs 
  were identified, synthesized as peptides, and tested for binding to soluble 
  HLA.The immunogenicity of peptides that bound with moderate to high affinity 
  was subsequently assessed using HLA transgenic mice (CTL) and HLA. through this 
  process, 30 CTL and 16 HTL epitopes were selected as a set that would be most 
  udeful for vaccine design, based on epitope conservation amongst HBV sequences 
  and HLA-based predicted population coverage in diverse ethnic groups. For this 
  purpose, a web server, <a href="http://immunax.dfci.harvard.edu/PEPVAC/">PEPVAC</a>, 
  was used to identify the most conserved set of epitopes. 
  <p style="font-size:smaller;"> <a class="ModuleContent" href="http://home.comcast.net/~igabashvili/AbstractsSpring2008.htm#2nd">BACK</a>
  </p><p> 


</p></li></body></html>